Texas Roadhouse Misses Q3 2026 Estimates as Revenue Rises 9.5% to $1.57B
Revenue of $1.57B vs. $1.58B expected and adjusted EPS of $1.36 vs. $1.46; revenue up 9.5% from a year earlier.
Texas Roadhouse (TXRH) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $1.57 billion, up 9.5% from a year earlier, below the $1.58 billion estimate, and adjusted EPS was $1.36, up 8.8% from a year earlier, below the $1.46 estimate.
Shares fell 2.1% in after-hours trading as of 4:04 p.m. ET, to $187.79 from a $191.79 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $1.46 | $1.36 | Miss by 6.8% |
| Revenue | $1.58B | $1.57B | Miss by 0.5% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 8.8% | ▼ 26% |
| Revenue | ▲ 9.5% | ▼ 6.4% |
By our calculation, revenue was $7.8 million below the estimate and adjusted EPS was $0.10 below it. The QoQ column compares with the previous quarter's revenue of $1.68 billion and adjusted EPS of $1.85. The YoY column compares with $1.44 billion and $1.25 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 5 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $1.44 billion, $1.48 billion, $1.63 billion, $1.68 billion and $1.57 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $1.31 and revenue of $1.62 billion next quarter, based on 17 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 9.5% increase to $1.57 billion.
- Estimate record. Whether Texas Roadhouse returns to beating EPS estimates, which it did in 3 of its last 8 reports.
- Related coverage. See our reports on Globus Medical, DENTSPLY SIRONA, Trupanion and TransMedics.
Sources: Results are from Texas Roadhouse's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Texas Roadhouse's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Globus Medical Q3 2026 EPS Tops Estimates at $1.23, but Revenue Misses at $763.7M
EarningsDENTSPLY SIRONA Misses Q3 2026 Estimates as Revenue Falls 7.5% to $836.0M
EarningsTrupanion Beats Q3 2026 Estimates as Revenue Rises 11% to $405.6M
EarningsTransMedics Beats Q3 2026 Estimates as Revenue Rises 41% to $203.0M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.